A new smartphone app could allow doctors and would-be parents receiving in vitro fertilization treatment to monitor the growth of embryos in a lab thousands of miles away.
The technology, being developed by Sydney-based Genea, is the latest example of how innovation in the global IVF industry—tipped by some analysts to be worth US$14 billion in 2020—is gathering pace. It …
RPMG’s Dr. Arthur Wisot was quoted in a Scientific American article on the new EEVA system. RPMG was involved in the study that led to FDA clearance of the device.
The Early Embryo Viability Assessment (EEVA) test is the only such FDA–approved technology designed to analyze embryos and help fertility specialists select the embryo or embryos most likely to proceed …
The Eeva Test is now commercially available in the United States. This breakthrough technology, recently cleared by the FDA, is designed to help fertility clinics select the best embryos during in vitro fertilization (IVF) to aid in their effort to provide the best chance of a successful pregnancy.
The Eeva Test is a first-in-class, non-invasive predictive test that enhances the …
We are pleased to announce the availability of the Early Embryo Viability Assessment Test (Eeva) to our patients undergoing an IVF cycle. RPMG was part of the study that led to FDA approval of the procedure.
Eeva is an FDA approved test using time-lapsed video to analyze early embryo development and aid in the selection of the best embryo for …